Pipeline
Aqilion has four development programs, in various stages of development, in its pipeline.
All programs focus on developing novel innovative treatments for chronic inflammatory diseases for which few or no treatments are available and where there is currently a clear patient need.
Target
Drug Candidate
Target Discovery
Development of Drug Candidate
IND enabling preclinical development
Phase 1
Phase 2
Partner
JAK1
AQ280
AhR
AQ312
TAK1
Not disclosed
PKCtheta
Not disclosed